Holoubek A - Search Results

1

A novel germline hyperactivating JAK2 mutation L604F.

Dvořáček L, Marková J, Holoubek A, Grebeňová D, Kundrát D, Kuželová K, Schwarz J. Dvořáček L, et al. Among authors: holoubek a. Ann Hematol. 2023 Oct;102(10):2725-2734. doi: 10.1007/s00277-023-05423-y. Epub 2023 Aug 28. Ann Hematol. 2023. PMID: 37639050 Free PMC article.

2

Adhesion structures in leukemia cells and their regulation by Src family kinases.

Röselová P, Obr A, Holoubek A, Grebeňová D, Kuželová K. Röselová P, et al. Among authors: holoubek a. Cell Adh Migr. 2018 May 4;12(3):286-298. doi: 10.1080/19336918.2017.1344796. Epub 2017 Aug 18. Cell Adh Migr. 2018. PMID: 28678601 Free PMC article.

3

PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.

Grebeňová D, Holoubek A, Röselová P, Obr A, Brodská B, Kuželová K. Grebeňová D, et al. Among authors: holoubek a. Sci Rep. 2019 Nov 20;9(1):17171. doi: 10.1038/s41598-019-53665-6. Sci Rep. 2019. PMID: 31748572 Free PMC article.

4

Group I p21-activated kinases in leukemia cell adhesion to fibronectin.

Kuželová K, Obr A, Röselová P, Grebeňová D, Otevřelová P, Brodská B, Holoubek A. Kuželová K, et al. Among authors: holoubek a. Cell Adh Migr. 2021 Dec;15(1):18-36. doi: 10.1080/19336918.2021.1872760. Cell Adh Migr. 2021. PMID: 33464167 Free PMC article.

5

Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells.

Kuželová K, Grebeňová D, Holoubek A, Röselová P, Obr A. Kuželová K, et al. Among authors: holoubek a. PLoS One. 2014 Mar 24;9(3):e92560. doi: 10.1371/journal.pone.0092560. eCollection 2014. PLoS One. 2014. PMID: 24664099 Free PMC article.

6

Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM.

Brodská B, Kráčmarová M, Holoubek A, Kuželová K. Brodská B, et al. Among authors: holoubek a. PLoS One. 2017 Apr 6;12(4):e0175175. doi: 10.1371/journal.pone.0175175. eCollection 2017. PLoS One. 2017. PMID: 28384310 Free PMC article.

7

AML-associated mutation of nucleophosmin compromises its interaction with nucleolin.

Šašinková M, Holoubek A, Otevřelová P, Kuželová K, Brodská B. Šašinková M, et al. Among authors: holoubek a. Int J Biochem Cell Biol. 2018 Oct;103:65-73. doi: 10.1016/j.biocel.2018.08.008. Epub 2018 Aug 18. Int J Biochem Cell Biol. 2018. PMID: 30130654

8

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization.

Šašinková M, Heřman P, Holoubek A, Strachotová D, Otevřelová P, Grebeňová D, Kuželová K, Brodská B. Šašinková M, et al. Among authors: holoubek a. Sci Rep. 2021 Jan 13;11(1):1084. doi: 10.1038/s41598-020-80224-1. Sci Rep. 2021. PMID: 33441774 Free PMC article.

9

Combined treatment with low concentrations of decitabine and SAHA causes cell death in leukemic cell lines but not in normal peripheral blood lymphocytes.

Brodská B, Holoubek A, Otevřelová P, Kuželová K. Brodská B, et al. Among authors: holoubek a. Biomed Res Int. 2013;2013:659254. doi: 10.1155/2013/659254. Epub 2013 Aug 13. Biomed Res Int. 2013. PMID: 24000324 Free PMC article.

10

Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.

Brodská B, Holoubek A, Otevřelová P, Kuželová K. Brodská B, et al. Among authors: holoubek a. J Cell Biochem. 2016 Jun;117(6):1319-29. doi: 10.1002/jcb.25420. Epub 2015 Nov 9. J Cell Biochem. 2016. PMID: 26505272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page